Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewYM 155 is a survivin suppressor. Down-regulates survivin expression and sensitizes human NSCLC cell lines to radiation. Enhances radiation-induced tumor regression in nude mice bearing NSCLC xenografts. Also induces apoptosis in TRAIL-resistant glioma cells in vitro. YM 155 is also an inhibitor of ILF3 (interleukin enhancer binding factor 3), an RNA-binding protein. It reduces thermal and mechanical hypersensitivity in a mice model of inflammatory pain.
YM 155 is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.
M. Wt | 443.29 |
Formula | C20H19BrN4O3 |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 781661-94-7 |
PubChem ID | 46931000 |
InChI Key | OOLCTHGNPMKPRV-UHFFFAOYSA-M |
Smiles | COCCN1C(C)=[N+](C2=C1C(C3=CC=CC=C3C2=O)=O)CC4=NC=CN=C4.[Br-] |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
water | 44.33 | 100 | |
DMSO | 8.87 | 20 |
The following data is based on the product molecular weight 443.29. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.26 mL | 11.28 mL | 22.56 mL |
5 mM | 0.45 mL | 2.26 mL | 4.51 mL |
10 mM | 0.23 mL | 1.13 mL | 2.26 mL |
50 mM | 0.05 mL | 0.23 mL | 0.45 mL |
References are publications that support the biological activity of the product.
Iwasa et al (2008) Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines. Clin.Cancer Res. 14 6496 PMID: 18927289
Premkumar et al (2013) Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway. J.Pharmacol.Exp.Ther. 346 201 PMID: 23740602
Serafini et al (2023) SARS-CoV-2 airway infection results in the development of somatosensory abnormalities in a hamster model. Sci.Signal. 16 eade4984 PMID: 37159520
If you know of a relevant reference for YM 155, please let us know.
Keywords: YM 155, YM 155 supplier, YM155, survivin, suppressor, inhibits, inhibitors, induces, apoptosis, sepantronium, bromide, ILF3, interleukin, enhancer, binding, factor, 3, inflammatory, pain, Inhibitor, of, Apoptosis, (IAP), DNA,, RNA, and, Protein, Synthesis, 6491, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for YM 155 include:
Eric et al (2019) Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity. Dev Cell 49 393-408.e7 PMID: 30982660
Serafini et al (2023) SARS-CoV-2 airway infection results in the development of somatosensory abnormalities in a hamster model. Sci.Signal. 16 eade4984 PMID: 37159520
Do you know of a great paper that uses YM 155 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review YM 155 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.